Tid Tittel Kategori Vedlegg
18.11.2026
08:00
Photocure partners with Clinigen on Named Patient Program broadening Access to Hexvix/Cysview (hexaminolevulinate HCl) -
1
09.11.2026
08:00
Photocure Provides Update on AssureMDx and Anticipated Medicare Coverage Timeline -
1
28.10.2026
08:00
Photocure ASA: Results for the third quarter of 2026 RAPPORT RAP
3
27.10.2026
15:57
Photocure ASA - Share option grant to new CFO INSIDEHANDEL INS
2
22.10.2026
17:05
Photocure ASA - New CFO Appointed -
1
20.10.2026
13:32
Photocure ASA: Invitation to presentation of third quarter 2026 financial results -
1
14.08.2026
17:45
Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II -
1
11.08.2026
08:00
Cost neutrality of BLC versus WLC in a real-world setting demonstrated by new OPTUM study in the U.S. -
1
07.08.2026
18:03
Photocure ASA: Notification of primary insider transactions INSIDEHANDEL INS
2
07.08.2026
18:00
Photocure ASA - Share option grant to members of the board of directors INSIDEHANDEL INS
2
04.08.2026
08:00
Photocure ASA: Asieris counterclaim on milestone payment arbitration INFORMASJON INF -
29.07.2026
21:48
Photocure ASA - Share option grant INSIDEHANDEL INS
2
29.07.2026
08:00
Photocure ASA: Results for the second quarter of 2026 RAPPORT RAP
3
22.07.2026
08:56
Photocure ASA: Invitation to presentation of second quarter 2026 financial results -
1
14.07.2026
08:07
Photocure ASA - Share option grant -
1
30.06.2026
15:31
Photocure ASA - CFO transition -
1
26.06.2026
19:18
Photocure ASA: Annual general meeting held -
2
08.06.2026
18:09
Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer -
1
05.06.2026
14:56
Photocure ASA - Notice of the Annual General Meeting 26 June 2026 -
6
04.06.2026
16:30
Photocure ASA to Acquire Vesica Health Inc., Strengthening Leadership in Bladder Cancer Diagnostics INFORMASJON INF
2
18.05.2026
17:00
AUA 2026: new studies demonstrated Blue Light Cystoscopy benefits in high-risk NMIBC management and cost comparison study -
1
07.05.2026
07:00
Photocure ASA: Results for the first quarter of 2026 RAPPORT RAP
3
04.05.2026
08:00
New health economic methodology published: comparing cost-effectiveness of BLC versus NBI imaging technology in bladder cancer -
1
30.04.2026
09:00
Photocure ASA: Invitation to presentation of first quarter 2026 financial results -
1
27.04.2026
09:00
Photocure ASA: Annual Report 2025 RAPPORT RAP
3